Mohiba Tareen, MD
Dermatology · Roseville, MNNPI 1740448117
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,136 of the $24,184 with a category attached, or 99.8%. AbbVie accounts for 99.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $7,805 and has fallen 62.7% since, to $2,915 in 2024. Among dermatology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $1727.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$24K
- Organogenesis Inc.$19
- Galderma Laboratories, L.p.$15
- Strata Skin Sciences, Inc.$15
What the payments were for
- Speaking & faculty fees$24,136100%
- Food & beverage$490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $24,136 |
| Organogenesis Inc. | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Strata Skin Sciences, Inc. | 2 | $15 |
How this compares
$24,184 in reported general payments places this provider in the 95th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desonide | 45 | $4,800 |
| Cephalexin | 1,175 | $4,798 |
| Ketoconazole | 137 | $3,666 |
| Clobetasol Propionate | 83 | $3,614 |
| Metronidazole | 53 | $2,538 |
| Mupirocin | 328 | $2,399 |
| Azelaic Acid | 16 | $2,298 |
| Doxycycline Monohydrate | 280 | $1,639 |
| Triamcinolone Acetonide | 55 | $972 |
| Doxycycline Hyclate | 40 | $417 |
| Ammonium Lactate | 19 | $389 |
| ValacyclovirValacyclovir Hcl | 29 | $352 |
| Ciprofloxacin Hcl | 39 | $176 |
| Fluconazole | 17 | $127 |
| Hydrocortisone | 21 | $100 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Roseville
- Kristina ShafferEagan$538K
- Margareth Pierre-LouisMinneapolis$439K
- Maria HordinskyMinneapolis$85K
- Afsaneh AlaviRochester$71K
- Todd SeelhammerSaint Paul$63K
- Brittney SchultzMinneapolis$52K
- David PearsonMinneapolis$46K
- Phillip EckerWayzata$31K
- Noah GoldfarbMinneapolis$30K
- Saranya WylesRochester$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.